期刊文献+

大肠癌组织中EphA2,VEGF和MMP9蛋白的表达及其相关性研究 被引量:4

The correlation and expression of EphA2 ,VEGF and MMP9 proteins in human colorectal carcinoma
下载PDF
导出
摘要 为探讨大肠癌组织中EphA2,VEGF和MMP9蛋白的表达及其与大肠癌生物学行为的关系。笔者应用免疫组织化学S-P法检测69例大肠癌组织及30例远癌肠黏膜中EphA2,VEGF,MMP9蛋白的表达。结果示,大肠癌组织中EphA2蛋白(100%)表达显著高于远癌肠黏膜(80.0%)(P<0.01),且与Dukes分期、肿瘤组织分化程度及肉眼类型有关(P<0.05),而与年龄无关(P>0.05)。VEGF蛋白及MMP9蛋白在大肠癌中的表达均显著高于远癌肠黏膜(均P<0.01),与Dukes分期有关(P<0.05),但与年龄、肿瘤组织分化程度及肉眼类型等无关(均P>0.05)。EphA2蛋白在大肠癌中的表达与VEGF,MMP9呈正相关(r1=0.404,P1=0.000;r2=0.282,P2=0.000)。提示联合检测EphA2,VEGF和MMP9有助于对大肠癌侵袭及转移能力的评估,对大肠癌的预后判断可能具有一定的临床意义。
出处 《中国普通外科杂志》 CAS CSCD 2007年第7期696-699,共4页 China Journal of General Surgery
  • 相关文献

参考文献8

  • 1Lindberg RA,Hunter T.cDNA cloning and characterization of Eck,an epithelial cell receptor protein-tyrosine kinase in eph/Elk family of protein kinases[J].Mol Cell Biol,1990,10(12):6316-6324.
  • 2Sulman EP,Tang XX,Allen C,et al.a human eph-related gene,maps to 1p36.1,a common region of alteration in human cancers[J].Genomics,1997,40(2):371-374.
  • 3Brantley-Sieders D,Parker M,Chen J.Eph receptor tyrosine kinases in tumor and tumor microenvironment[J].Curr Pharm Des,2004,10(27):3431-3442.
  • 4Kinch MS,Carles-Kinch,K.Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer[J].Clin Exp Metastasis,2003,20(1):59-68.
  • 5Kinch MS,Mary-Beth M,David H,et al.Predictive Value of the EphA2 Receptor Tyrosine Kinase in Lung Cancer Recurrence and Survival[J].Advances in Brief,2003,9(2):613-618.
  • 6Ojima T,Takagi H,Suzuma K,et al.EphrinA1 Inhibits Vascular Endothelial Growth Factor-Induced Intracellular Signaling and Suppresses Retinal Neovascularization and Blood-Retinal Barrier Breakdown[J].Am J Pathol,2006,168(1):331-339.
  • 7Brantley-Sieders DM,Fang WB,Hicks DJ,et al.Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression[J].FASEB J,2005,19(13):1884-1886.
  • 8Duxbury MS,Ito H,Zinner MJ,et al.EphA2:a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma[J].Oncogene,2004,23 (7),1448-1456.

同被引文献30

  • 1冯延平,黄涛,高军,常青,秦仁义.EphA2与E-cadherin在胰腺癌中的表达及其意义[J].中国普通外科杂志,2005,14(12):914-917. 被引量:8
  • 2吴泽宇,罗中仁,万进,杜嘉林.中下段直肠癌E-cadherin,MMP-2和VEGF表达与肿瘤侵袭转移的关系[J].中国普通外科杂志,2007,16(4):387-389. 被引量:13
  • 3David JR. Delayed hypersensitivity in vitro:its mediation by cell-free substances formed by lymphoid cell-antigen interaction[J]. Proc Natl Acad Sci USA,1966,56(1 ) :72 - 77.
  • 4Bloom BR, Bennettm B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity [ J ]. Science,1966,153(731) :80-82.
  • 5Ren Y, Law S, Huang X, et al. Macrophage migration ilnhibitory factor stimulates angiogenic factor expression and correlates with differentiation and lymph node status in patients with esophageal squamous cell carcinoma [ J ]. Ann Surg, 2005,242(1):55 -63.
  • 6Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity [ J ]. Nat Rev Immunol, 2003,3(10) :791 -800.
  • 7Kamimura A, Kamachi M, Nishihira J, et al. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung [ J ] . Cancer, 2000,89(2) :334 -341.
  • 8del Vecchio MT, Tripodi SA, Arcuri F, et al. Macrophage migration inhibitory factor in prostatic adenocarcinoma : correlation with tumor grading and combination endocrine treatmentrelated changes [ J ] . Prostate, 2000,45 ( 1 ) : 51 - 57.
  • 9Wilson JM, Coletta PL, Cuthbert RJ, et al. Macrophage migration inhibitory factor promotes intestinal tumorigenesis [ J ] . Gastroenterology ,2005 , 129 ( 5 ) : 1485 - 1503.
  • 10Liao H, Bucala R, Mitchell RA. Adhesion-dependent signaling by macrophage migration inhibitory factor ( MIF ) [ J ] . J Biol Chem,2003, 278 ( 1 ) :76 - 81.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部